#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	5692	16S	1529	1529	100.0	16S.l6.c17.ctg.1	2617	496.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1728	1728	C	694	C	604	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10348	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3952	610.0	0	.	n	.	0	T695C	SNP	695	695	T	1294	1294	C	825	C,A,T	714,3,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10348	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3952	610.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2237	2237	G	670	G,A,C	427,179,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10348	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3952	610.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2570	2570	C	660	C,T,G	592,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10348	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3952	610.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2644	2644	A	607	A,G,T,C	543,1,1,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	10348	23S	2890	2890	99.9	23S.l6.c4.ctg.1	3952	610.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	3196	3196	C	690	C,T	608,2	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_Y_01480c	folP.WHO_Y_01480c	1	1	27	394	folP	855	855	100.0	folP.l6.c4.ctg.1	2118	44.6	1	SNP	p	R229S	1	.	.	685	687	AGC	1358	1360	AGC	66;65;65	A;G;C	62;62;60	folP.WHO_Y_01480c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	902	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	53.1	1	SNP	p	S91F	1	.	.	271	273	TTC	883	885	TTC	65;65;65	T;T;C	58;56;60	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	902	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	53.1	1	SNP	p	G95N	0	.	.	283	285	GGC	895	897	GGC	65;66;66	G,T;G;C	59,1;62;62	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	902	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3933	53.1	1	SNP	p	D95G	1	.	.	283	285	GGC	895	897	GGC	65;66;66	G,T;G;C	59,1;62;62	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	434	mtrR	633	633	100.0	mtrR.l15.c4.ctg.1	1823	56.1	1	SNP	p	G45D	0	.	.	133	135	GGC	721	723	GGC	99;99;99	G;G;C	82;81;83	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	250	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1580	37.2	0	.	n	.	0	A197.	DEL	197	197	A	874	874	A	90	A	78	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1120	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3568	73.9	1	SNP	p	D86N	0	.	.	256	258	GAC	882	884	GAC	87;88;93	G;A;C,A	66;61;72,1	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1120	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3568	73.9	1	SNP	p	R87I	0	.	.	259	261	CGT	885	887	CGT	94;94;96	C;G;T,G	80;73;74,1	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1120	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3568	73.9	1	SNP	p	S87R	1	.	.	259	261	CGT	885	887	CGT	94;94;96	C;G;T,G	80;73;74,1	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1120	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3568	73.9	1	SNP	p	R87W	0	.	.	259	261	CGT	885	887	CGT	94;94;96	C;G;T,G	80;73;74,1	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	1120	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3568	73.9	1	SNP	p	S88P	0	.	.	262	264	TCC	888	890	TCC	96;95;94	T,G;C,T,G;C	80,1;80,1,1;80	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	736	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3169	54.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1851	1853	GGC	47;47;46	G;G,A;C	46;43,1;41	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	A311V	0	.	.	931	933	GCC	1526	1528	GCC	133;134;134	G,A;C;C	116,1;118;118	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	I312M	1	.	.	934	936	ATG	1529	1531	ATG	134;136;136	A;T;G	118;120;119	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	T316P	0	.	.	946	948	ACC	1541	1543	ACC	140;141;141	A;C,A;C	120;123,1;124	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	V316T	1	.	.	946	948	ACC	1541	1543	ACC	140;141;141	A;C,A;C	120;123,1;124	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	T483S	0	.	.	1447	1449	ACC	2042	2044	ACC	116;116;117	A,T,C;C,A;C	98,2,1;97,1;103	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	A501V	0	.	.	1501	1503	GCG	2096	2098	GCG	111;109;109	G;C,A;G,A,T	95;86,1;87,1,1	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	A501P	0	.	.	1501	1503	GCG	2096	2098	GCG	111;109;109	G;C,A;G,A,T	95;86,1;87,1,1	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2219	2221	GGT	70;71;71	G;G;T,G	65;66;65,2	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2228	2230	AGC	66;66;65	A,C,G;G;C,A,G	50,1,1;57;53,1,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	962	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2611	85.6	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2246	2248	CCG	56;54;54	C;C;G,C	44;38;42,2	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	1588	ponA	2397	2397	100.0	ponA.l6.c17.ctg.1	3610	103.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1903	1905	CCG	135;136;136	C,A,G;C,T,A;G,C	116,1,1;120,2,1;105,4	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	560	porA	1146	1146	99.91	porA.l15.c4.ctg.1	2372	55.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	826	826	C	51	C	40	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	806	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2285	82.8	1	SNP	p	G120K	1	.	.	358	360	AAG	925	927	AAG	115;115;121	A,C;A;G	103,1;105;109	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	806	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2285	82.8	1	SNP	p	N121D	0	.	.	361	363	AAC	928	930	AAC	121;120;120	A;A;C	107;110;107	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	806	porB1b	1038	1038	100.0	porB1b.l15.c4.ctg.1	2285	82.8	1	SNP	p	A121N	1	.	.	361	363	AAC	928	930	AAC	121;120;120	A;A;C	107;110;107	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	2828	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	5351	123.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	414	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1571	63.7	1	SNP	p	V57M	1	.	.	169	171	ATG	779	781	ATG	128;126;127	A;T;G	115;115;116	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
